WellGen’s mission is to discover and develop Medical Foods for inflammation-based diseases using natural products that are safe. Medical Foods, as defined by FDA are formulated to be consumed by patients under the supervision of a physician and intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation. WellGen’s multi-gene approach more closely resembles what happens in nature… we will build differentiated products based on natural products chemistry, nutrigenomics, and strong preclinical and clinical research.
Robert J. Bertoldi- Acting Chief Executive Officer
Board of Directors
Richard C.E. Morgan - (Chairman) Chief Executive Officer, Amphion Innovations
Richard Laster - (Vice Chairman) Management Consultant, former Chief Executive Officer, DNA Plant Technology Corp., EVP, General Foods, President, Maxwell House Coffee
Robert J. Bertoldi - President and Chief Financial Officer, Amphion Innovations
Irwin Engelman - Former Chief Financial Officer, General Foods Corp.
Scott Korman - President, Nashone Inc.
Dr. Laura Philips - Former Chief Operating Officer, NexGenix Pharmaceuticals; former Executive, Corning, Inc.
Dr. William R. Sharp Partner - GNP LLC
Bruce Williams - Non-executive Director